6 results
8-K
ADVM
Adverum Biotechnologies Inc
8 Feb 24
Regulation FD Disclosure
8:45am
Demographics
The LUNA trial is an ongoing double-masked, randomized, Phase 2 trial. 60 patients with wet AMD were enrolled equally across two dose
8-K
EX-99.1
ADVM
Adverum Biotechnologies Inc
8 Feb 24
Regulation FD Disclosure
8:45am
Demographics and Baseline Characteristics Demographics and Baseline Characteristics Ixo-vec 6E10 vg/eye N = 30 Ixo-vec 2E11 vg/eye N = 30 LUNA Total N
- Prev
- 1
- Next